Skip to nav Skip to content

IDSA Media Briefing: COVID-19 Vaccine Progress Report

Facebook Twitter LinkedIn Email

A media briefing with experts from the Infectious Diseases Society of America to discuss coronavirus and COVID-19 developments and answer questions.

Topical Agenda for December 3 Briefing:

IDSA experts will discuss COVID-19 vaccines currently being studied:
- Differences between vaccine types
- Efficacy, safety profiles, and unknowns
- COVID-19 vaccine development and research process
- Questions from media

FEATURING:
C. Buddy Creech, MD, MPH, FPIDS—Nashville, TN
Member, Infectious Diseases Society of America
Director, Vanderbilt Vaccine Research Program
Principal Investigator, Phase III trial for SARS-CoV-2 vaccine (Moderna)
Principal Investigator, Phase III trial for SARS-CoV-2 vaccine (Johnson & Johnson)

Kathleen M. Neuzil, MD, MPH, FIDSA—Baltimore, MD
Fellow, Infectious Diseases Society of America
Director, Center for Vaccine Development and Global Health
Myron M. Levine Professor in Vaccinology, University of Maryland School of Medicine
Co-Director, COVID-19 Prevention Network, the NIH network of sites engaged in the trials

Chris Busky, CAE (Moderator)
Chief Executive Officer—Infectious Diseases Society of America

Latest Media

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.